Article: TCR-based T cell immunotherapy for AML: Multidimensional aids in optimising treatment and patient identification

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer